Related Experiment Video
Updated: Jun 3, 2026
In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
Published on: August 9, 2017
Activation of cardiomyocytes depending on their proximity to human bone marrow stem cells
Insights
Bone marrow stem cells (BMCs) can trigger cellular responses in cardiomyocytes. BMCs increase expression of c-Myc, ATF-3, CDK2, and CDK4, and enhance beta-adrenoceptor density in nearby heart cells.
Area of Science:
- Cardiology
- Stem Cell Biology
- Cellular Signaling
Background:
- Bone marrow stem cells (BMCs) are investigated for regenerative potential.
- Understanding cardiomyocyte response to BMCs is crucial for therapeutic applications.
Purpose of the Study:
- To determine if bone marrow stem cell (BMC) treatment elicits an in vitro cellular response in cardiomyocytes.
- To investigate the molecular mechanisms and signaling pathways involved.
Main Methods:
- Neonatal rat cardiomyocyte cultures were co-cultured with human BMCs.
- Immunohistological staining was used to detect c-Myc, ATF-3, CDK2, and CDK4 expression.
- Beta-adrenoceptor density was quantified using histoautoradiography with [125I]-iodocyanopindolol (ICYP).
Main Results:
- BMC presence significantly upregulated c-Myc, ATF-3, CDK2, and CDK4 in adjacent cardiomyocytes.
- Cardiomyocytes near BMCs exhibited significantly higher beta-adrenoceptor density.
- These effects diminished with increasing distance from the BMCs.
Conclusions:
- A small number of BMCs can influence a larger population of cardiomyocytes.
- BMCs activate intracellular signaling cascades and enhance beta-adrenoceptor density in cardiomyocytes.
- This study provides insights into BMC-cardiomyocyte interactions and potential therapeutic mechanisms.
Abstract:
Our study aimed to elucidate whether bone marrow stem cell (BMC) treatment might result in a cellular response in cardiomyocytes IN VITRO. Subconfluent neonatal rat cardiomyocyte cultures were cocultured for three days with Vybrant CM-DiI labeled BMC from human sternal bone marrow and underwent immunohistological staining for the proto-oncogene c-Myc and the cell cycle proteins CDK2, CDK4 and ATF-3. β-adrenoceptor density was analyzed using [125I]-iodocyanopindolol (ICYP) histoautoradiography. Quantitative analysis of immunohistochemical images revealed significantly increased expression and upregulation of c-Myc, and its downstream targets ATF-3, CDK2 and CDK4 in neighboring cardiomyocytes to BMC, depending on their distance to the BMC compared to cardiomyocytes far from the BMC. Histoautoradiography revealed a significantly higher β-adrenoceptor density in cardiomyocytes in the immediate vicinity to the BMC. With increasing distance to the BMC, β-adrenoceptor density in cardiomyocytes declined. Thus, a small number of BMC can affect a larger number of cardiomyocytes by activating an intracellular signaling cascade and enhancing β-adrenoceptor density.
